BRAF and central nervous system cancer: Both pharmacological inhibition of MEK1 / 2, rapid downstream phosphorylation sites of BRAF, and stable silencing of BRAF through lentiviral transduction of shRNA prevented proliferation and stopped the formation of advanced tumor cells derived from low‐grade gliomas.39